Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Major |
Duration of illness (i.e., until drainage stops or can be contained by a dressing) |
“Major” defined as “Dressing does not contain drainage adequately” |
|
Minor or limited |
Standard precautions needed if dressings cover and contain drainage. Note: standard precautions includes the use of gloves when touching blood, body fluids, and non-intact skin. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Multi-drug resistant (defined as carbapenemase-producing) |
See Multidrug resistant organisns ( MDRO) for further definitions |
||
Non-carbapenemase-producing |
See Multidrug resistant organisns ( MDRO) for further definitions |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Postexposure chemoprophylaxis for some blood exposures. See Bloodborne Pathogens Exposure Plan (https://ucsf.app.box.com/s/teqpxzwqao266snuo8dxc3o871tr867c) for more details. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Duration of illness |
If Acute Flaccid Myelitis (AFM) is suspected, contact San Francisco DPH 415-554-2830 |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Conjunctivitis |
Duration of illness |
||
Gastroenteritis |
Duration of illness |
||
Respiratory infection |
Adult and Pediatric hematology/oncology/BMT patients: Duration of illness AND retest is negative. All other patients: Duration of symptoms |
If discrete or continuous aerosol generating procedure performed, post Aerosol Generating Procedure in progress sign. Wear the appropriate PPE during the procedure and if applicable, when entering the room 1 hr after the procedure. Refer to: Guidance for PPE use for High Risk Aerosol Generating Procedures' |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Cutaneous |
Use Contact + Standard if large amount of uncontained drainage. Wash hands with soap and water. |
||
Pulmonary |
Use Contact + Standard if large amount of uncontained drainage. Wash hands with soap and water. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
(viral encephalitides [eastern, western, Venezuelan equine encephalomyelitis; St Louis, California encephalitis; West Nile Virus] and viral fevers [dengue, yellow fever, Colorado tick fever]) |
Not transmitted from person to person except rarely by transfusion, and for West Nile virus by organ transplant, breastmilk or transplacentally. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Airborne + Contact + Standard if massive soft tissue infection with copious drainage and repeated irrigations required |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
|
Additional resources are available on the Avian Influenza web page |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
North American, cutaneous or pulmonary |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
B. pertussis |
Until 5 days of effective antibiotic therapy |
||
B. parapertussis |
Until 5 days of effective antibiotic therapy |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
See also: Food Poisoning |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
When clinical syndrome suspected and/or no organism identified on further testing |
Duration of illness |
Initiate isolation when test to rule out viral pathogens is ordered. Refer to isolation table for identified pathogen. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
(undulant, Malta, Mediterranean fever) |
Notify Microbiology when submitting specimens for culture from patients with known or suspected Brucellosis (415-353-1268) |